Better Care for PFAS Patients Act of 2026

# Better Care for PFAS Patients Act of 2026 - Summary **What the Bill Does** This bill would establish new federal programs and requirements aimed at improving healthcare for people exposed to PFAS (per- and polyfluoroalkyl substances), commonly known as "forever chemicals." PFAS are human-made chemicals found in many consumer products and industrial applications that can contaminate water supplies and accumulate in the human body. The bill would likely create medical registries, research initiatives, and healthcare guidelines to better identify, treat, and monitor patients affected by PFAS exposure. **Who It Affects and Key Provisions** The bill would primarily affect people living in areas with PFAS-contaminated water supplies—a growing concern across the U.S. It would also impact healthcare providers, public health agencies, and potentially manufacturers of PFAS-containing products.

While specific provisions aren't detailed in the available information, bills with this title typically propose actions such as establishing PFAS exposure registries, funding medical research into health effects, directing the EPA and Health and Human Services to develop clinical guidance, and potentially expanding healthcare access for affected populations. **Current Status** The bill is currently in committee and has not yet advanced to a floor vote in the Senate. As of now, it remains in the early legislative stage, meaning it has not been passed and would require further committee review and voting before becoming law.